Article

jdsupra.comjdsupra.com on 2021-08-10 22:01

Federal Circuit Tailors its Decision on Skinny Labels

As we sensed when we last wrote about the Federal Circuit’s handling of the infringement dispute over GlaxoSmithKline’s ("GSK") Coreg® product in ...

Related news